EMA
safety_alert
· 2009-01-16
Priority access for children during Myozyme supply shortage
Summary
EMA announces priority access for children during the supply shortage of Myozyme (alglucosidase alfa), to ensure treatment continuity for pediatric patients.
Upgrade for the full analysis, importance score, and drug timeline.